QLY Biotech Group Corp. financial data

Location
Carretera Turistica, Luperon, 12 Th Km, No. 7, Grand Parada, Puerto Plata, Dominican Republic
Fiscal year end
August 31
Latest financial report
10-Q - Q1 2023 - Apr 13, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -104 % +41.5%
Return On Equity 269 % +226%
Return On Assets -6.17K % -5757%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.9M shares 0%
Common Stock, Shares, Outstanding 3.9M shares 0%
Common Stock, Value, Issued 3.9K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Cost of Revenue 0 USD
General and Administrative Expense 28.9K USD +196%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.6K USD -562%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -28.9K USD -304%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 0 USD -100%
Accrued Liabilities, Current 4.85K USD
Liabilities, Current 19.7K USD +38.6%
Liabilities 19.7K USD +38.6%
Retained Earnings (Accumulated Deficit) -70.7K USD -69.3%
Stockholders' Equity Attributable to Parent -19.7K USD -64.9%
Liabilities and Equity 0 USD -100%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 1B shares +1233%
Common Stock, Shares, Issued 3.9M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Additional Paid in Capital 47.2K USD +81.7%
Preferred Stock, Shares Outstanding 0 shares